ABclonal Korea is a leader in biomolecular solutions for life sciences. Headquartered in Massachusetts, USA, ABclonal was established in 2011 for custom antibody production projects and has since introduced cutting-edge development technologies to supply biological research reagents and services with world-class scientists. Currently, through 4 branches and 55 global distributors worldwide, we strive to improve the quality of life sciences research by providing high-quality antibodies, recombinant proteins, ELISA Kits, NGS Prep Kits, and Enzymes related to molecular biology. ABclonal’s advanced technologies enable the development of custom IVD materials used in early research and development of in vitro diagnostic products and raw material development services. Our customers span the globe, including internationally renowned companies such as Novartis, Genetek, BGI Genomics, Novogene, 3DMed, and Maxim. #Biotechnology #LifeScience #Antibody #ResearchTools
Company Details
- Founded
- 2022
- Address
- 경기도 성남시 수정구 청계산로 4길 26-7 1f, 성남시,korea, Republic Of
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://abclonal.co.kr
- HQ
- 성남시
Abclonal Korea Questions
Abclonal Korea's website is https://abclonal.co.kr
Abclonal Korea's LinkedIn profile is https://www.linkedin.com/company/abclonal-korea
Abclonal Korea's industry is
Biotechnology Research
Abclonal Korea's top competitors are
Geneall Biotechnology,
Abclonal Uk Ltd,
Js Link Sequencing Lab (Formerly Dna Link),
The Neurodevelopmental Institute Of Nh, Llc,
Abclonal Technology Asia Pacific,
Kh Medical,
Dna Reference Lab Inc,
Labiskoma,
Genesystem,
Glory Biotech Corp..
Abclonal Korea's categories are Biotechnology Research
Abclonal Korea's founding year is 2022
